Literature DB >> 17264092

What's in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity.

N Iikuni1, A Nakajima, E Inoue, E Tanaka, H Okamoto, M Hara, T Tomatsu, N Kamatani, H Yamanaka.   

Abstract

OBJECTIVES: To examine whether a seasonal fluctuation exists with rheumatoid arthritis (RA) activity and to analyse seasonal effects of varying components that express disease activity in RA patients.
METHODS: A group of 1665 RA patients (mean age 57.2 yrs, mean disease duration 9.9 yrs) whose data were available for 10 consecutive phases from a large observational cohort study conducted at our institution from October 2000 to April 2005, bi-annually, were evaluated. Ten criteria were analysed to assess RA disease activity.
RESULTS: All criteria revealed decrease in disease activity during fall and increase in disease activity during spring, except for the physician's global assessment of disease activity in which significant differences were not observed between the two seasons.
CONCLUSIONS: We found definite seasonal differences in RA patients, both subjectively and objectively. RA disease activity was higher in spring and lower during fall. Seasonal changes may play an important role in evaluating disease activity of RA patients and should be taken into account when examining these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17264092     DOI: 10.1093/rheumatology/kel414

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  31 in total

1.  Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis.

Authors:  L Yazmalar; L Ediz; M Alpayci; O Hiz; M Toprak; I Tekeoglu
Journal:  Afr Health Sci       Date:  2013-03       Impact factor: 0.927

2.  The role of the hypothalamic-pituitary-adrenal axis in modulating seasonal changes in immunity.

Authors:  Kamau Pierre; Naomi Schlesinger; Ioannis P Androulakis
Journal:  Physiol Genomics       Date:  2016-06-24       Impact factor: 3.107

3.  Does rheumatoid arthritis disease activity correlate with weather conditions?

Authors:  E M Savage; D McCormick; S McDonald; O Moore; M Stevenson; A P Cairns
Journal:  Rheumatol Int       Date:  2014-10-24       Impact factor: 2.631

4.  Spatial modelling of rheumatoid arthritis in Turkey by geographic information systems (GIS).

Authors:  Ahmet İnanır; Hakan Mete Dogan; Osman Çeçen; Cisem Nildem Dogan
Journal:  Rheumatol Int       Date:  2013-07-06       Impact factor: 2.631

5.  Finding joy in poor health: The leisure-scapes of chronic illness.

Authors:  Julia McQuoid
Journal:  Soc Sci Med       Date:  2017-04-26       Impact factor: 4.634

6.  Effects of long-term corticosteroid usage on functional disability in patients with early rheumatoid arthritis, regardless of controlled disease activity.

Authors:  Eiichi Tanaka; Ajitha Mannalithara; Eisuke Inoue; Noriko Iikuni; Atsuo Taniguchi; Shigeki Momohara; Gurkirpal Singh; Hisashi Yamanaka
Journal:  Rheumatol Int       Date:  2010-12-16       Impact factor: 2.631

7.  On the analysis of complex biological supply chains: From Process Systems Engineering to Quantitative Systems Pharmacology.

Authors:  Rohit T Rao; Megerle L Scherholz; Clara Hartmanshenn; Seul-A Bae; Ioannis P Androulakis
Journal:  Comput Chem Eng       Date:  2017-06-03       Impact factor: 3.845

8.  Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.

Authors:  Mark R Tanner; Rajeev B Tajhya; Redwan Huq; Elizabeth J Gehrmann; Kathia E Rodarte; Mustafa A Atik; Raymond S Norton; Michael W Pennington; Christine Beeton
Journal:  Clin Immunol       Date:  2017-04-04       Impact factor: 3.969

9.  Quantitative Systems Pharmacology: A Framework for Context.

Authors:  Ioannis P Androulakis
Journal:  Curr Pharmacol Rep       Date:  2016-04-08

Review 10.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.